rs80358116
From SNPedia
Orientation | minus |
Stabilized | minus |
Geno | Mag | Summary |
---|---|---|
(A;G) | 6 | BRCA1 variant considered pathogenic for breast cancer |
(C;G) | 6 | BRCA1 variant considered pathogenic for breast cancer |
(G;G) | 0 | common in clinvar |
(G;T) | 6 | BRCA1 variant considered pathogenic for breast cancer |
Make rs80358116(A;A) |
Reference | GRCh38 38.1/141 |
Chromosome | 17 |
Position | 43104262 |
Gene | BRCA1 |
is a | snp |
is | mentioned by |
dbSNP | rs80358116 |
dbSNP (classic) | rs80358116 |
ClinGen | rs80358116 |
ebi | rs80358116 |
HLI | rs80358116 |
Exac | rs80358116 |
Gnomad | rs80358116 |
Varsome | rs80358116 |
LitVar | rs80358116 |
Map | rs80358116 |
PheGenI | rs80358116 |
Biobank | rs80358116 |
1000 genomes | rs80358116 |
hgdp | rs80358116 |
ensembl | rs80358116 |
geneview | rs80358116 |
scholar | rs80358116 |
rs80358116 | |
pharmgkb | rs80358116 |
gwascentral | rs80358116 |
openSNP | rs80358116 |
23andMe | rs80358116 |
SNPshot | rs80358116 |
SNPdbe | rs80358116 |
MSV3d | rs80358116 |
GWAS Ctlg | rs80358116 |
Max Magnitude | 6 |
rs80358116 represents a rare variant in the BRCA1 gene. It is also rare in that all three possible alternative alleles are known, and, all three are reported to be pathogenic for breast cancer in ClinVar.
The major allele is rs80358116(G). The three alternatives are c.302-1G>T, c.302-1G>C and c.302-1G>A, the latter of which appears to be tested on at least some 23andMe chips under the pseudonym i5009555.
ClinVar | |
---|---|
Risk | rs80358116(A;A) rs80358116(C;C) rs80358116(T;T) |
Alt | rs80358116(A;A) rs80358116(C;C) rs80358116(T;T) |
Reference | Rs80358116(G;G) |
Significance | Pathogenic |
Disease | Breast-ovarian cancer Familial cancer of breast |
Variation | info |
Gene | BRCA1 |
CLNDBN | Breast-ovarian cancer, familial 1 Familial cancer of breast |
Reversed | 1 |
HGVS | NC_000017.10:g.41256279C>A; NC_000017.10:g.41256279C>G; NC_000017.10:g.41256279C>T |
CLNSRC | Breast Cancer Information Core (BRCA1) Database of BRCA1 and BRCA2 sequence variants that have been clinically reclassified by a quantitative integrated evaluation |
CLNACC | RCV000112247.1, RCV000048044.2, RCV000191156.2, RCV000048043.2, RCV000112246.1, |